Fig. 3From: ATG4B and pS383/392-ATG4B serve as potential biomarkers and therapeutic targets of colorectal cancerThe association of phosphorylated ATG4B with demographic, clinicopathologic factors and radiation therapy on overall survival in colorectal cancer patients. (A) Kaplan-Meier plots were used to determine the association of demographic factors with phosphorylated ATG4B (pS383/392-ATG4B) on overall survival, including gender and (B) age (< or > 60 years old). The association of pS383/392-ATG4B with clinicopathologic factors on overall survival was further inspected, such as (C) differentiation (I: well, II: moderate and III: poor), (D) clinicopathologic staging AJCC (I + II and III + IV), (E) T stages (tumor size, III + IV) and (F) N stages (lymph nodes invasion, 0 and 1 + 2). (G) The association of pS383/392-ATG4B with radiation therapy on overall survival was also evaluated. The significance of pS383/392-ATG4B protein levels on survival is shown with log rankBack to article page